Article
The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
Carcinogenesis - 1 Feb 2016
Fogli Anne, Chautard Emmanuel, Vaurs-Barrière Catherine, Pereira Bruno, Müller-Barthélémy Mélanie, Court Franck, Biau Julian, Pinto Afonso Almeida, Kémény Jean-Louis, Khalil Toufic, Karayan-Tapon Lucie, Verrelle Pierre, Costa Bruno Marques, Arnaud Philippe
Abstract excerpt
Malignant gliomas are the most common primary brain tumors. Grade III and IV gliomas harboring wild-type IDH1/2 are the most aggressive. In addition to surgery and radiotherapy, concomitant and adjuvant chemotherapy with temozolomide (TMZ) significantly improves overall survival (OS). The methylation status of the O(6)-methylguanine-DNA methyltransferase (MGMT) promoter is predictive of TMZ response and a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
